CareDx company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

caredx.com

Founded Year

1998

Stage

IPO | IPO

Total Raised

$140.91M

Date of IPO

7/18/2014

Market Cap

1.38B

Stock Price

25.86

About CareDx

CareDx (NASDAQ: CDNA) develops clinically differentiated, high-value, non-invasive gene-expression test and surveillance solutions for transplant recipients. The company commercializes AlloMap, which aids clinicians in identifying heart transplant recipients with stable graft function.

CareDx Headquarter Location

3260 Bayshore Boulevard

Brisbane, California, 94005,

United States

415-287-2300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CareDx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CareDx is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CareDx Patents

CareDx has filed 3 patents.

The 3 most popular patent topics include:

  • Abnormal psychology
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/30/2021

Transplantation medicine, Information technology management, Medical terminology, Psychiatric diagnosis, Abnormal psychology

Application

Application Date

6/30/2021

Grant Date

Title

Related Topics

Transplantation medicine, Information technology management, Medical terminology, Psychiatric diagnosis, Abnormal psychology

Status

Application

Latest CareDx News

CareDx Investor Alert

May 22, 2022

CareDx Investor Alert Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In CareDx To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 22, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against CareDx Inc. ("CareDx" or the "Company") (NASDAQ: CDNA). If you suffered losses exceeding $50,000 investing in CareDx stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/CDNA . There is no cost or obligation to you. Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia. On October 28, 2021, in its 10-Q filing, CareDx disclosed that the Department of Justice ("DOJ") issued a civil investigative demand ("CID") "requesting that the Company produce certain documents in connection with a False Claims Act investigation being conducted by the DOJ regarding certain business practices related to our kidney testing and phlebotomy services, and a subpoena from the United States Securities and Exchange Commission (SEC) in relation to an investigation by the SEC in respect of matters similar to those identified in the CID, as well as certain of our accounting and public reporting practices." On this news, the price of the Company's stock declined. On this news the stock dropped as low as $50.53, a 28% drop from the previous day's closing price. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124852 Sign up for Alerts Sign up to receive news releases by email for Faruqi & Faruqi LLP or all companies belonging to the Banking/Financial Services industry.

CareDx Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CareDx Rank

  • When was CareDx founded?

    CareDx was founded in 1998.

  • Where is CareDx's headquarters?

    CareDx's headquarters is located at 3260 Bayshore Boulevard, Brisbane.

  • What is CareDx's latest funding round?

    CareDx's latest funding round is IPO.

  • How much did CareDx raise?

    CareDx raised a total of $140.91M.

  • Who are the investors of CareDx?

    Investors of CareDx include Maryland Angels Council, Meridian Management Group and MDU Resources Group.

  • Who are CareDx's competitors?

    Competitors of CareDx include Cibiltech, BioGX, MolecularMD, IntelligentMDx, Roka Bioscience and 14 more.

You May Also Like

S
SideroGen

SideroGen, Inc. is focused on the development and manufacture of biomolecule purification products for applications in the fields of forensic science and clinical genomics. These products will be developed for processing very small samples, common to forensic science and cancer diagnostics. The core technology for these products is based on inert ferro-ceramic, paramagnetic particles of compositions that are specifically designed to be compatible with downstream DNA and protein analysis. This technology and its uses are exclusively owned and were developed by SideroGen, Inc.

IntelligentMDx Logo
IntelligentMDx

Intelligent Medical Devices, dba IntelligentMDx, develops and manufactures tests, under regulatory compliance, for a broad range of molecular based systems for use in clinical molecular diagnostics, drug development and applied science applications. Its aim is to translate the needs of the clinician, patient and partners into very specific, highly sensitive, robust clinically impactful tests, thus enabling caregivers worldwide to improve patient care.

S
Sidec Technologies

Sidec Technologies enables visualization of cellular events in 3-D at the molecular level

O
Oxford Molecular

Oxford Molecular aims to provide computational chemistry and molecular graphics to European and U.S. markets.

E
Evogen

This company, formerly known as Sceptor, is a global diagnostics, biological collection and detection systems company dedicated to improving the quality of life and world safety by meeting the needs of multiple markets, including research, clinical, environmental and biodefense diagnostics.

P
PolyAn

PolyAn Molecular Surface Engineering: fluorescent encoded polymer microspheres (beads), microarray slides and membranes for Pervaporation and organophilic Nanofiltration

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.